ACTU vs GOOGL · $49.0M cap vs P/E 26, rev $402.84B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Alphabet Inc Class A (GOOGL) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Alphabet Inc Class A (GOOGL) is a internet content & information company listed on US. It is led by Sundar Pichai.
ACTU does not have a complete income-statement cache yet.
Latest reported GOOGL revenue for 2025-12-31 was $402.84B. Net income was $132.17B. Revenue was up 15.1% from 2024-12-31 to 2025-12-31. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
ACTU currently screens at market cap $49.0M. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
Not investment advice. Open the ACTU and GOOGL stock pages for the full models.
Not investment advice.